20:07:36 EDT Fri 16 Apr 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Zenabis Global Inc
Symbol ZENA
Shares Issued 799,983,791
Close 2021-02-01 C$ 0.12
Recent Sedar Documents

Zenabis subsidiary receives EU GMP certification

2021-02-01 10:01 ET - News Release

Mr. Shai Altman reports

ZENABIS JOINT VENTURE RECEIVES EU GMP CERTIFICATION

Zenabis Global Inc.'s Maltese joint venture, ZenPharm Ltd., has received European Union good manufacturing practices (EU GMP) certification issued by the Malta Medicines Authority.

EU GMP certification is issued by the designated regulatory authority to pharmaceutical facilities that have passed a rigorous, regulator-led audit and inspection process. EU GMP certification is a requirement for export of medicinal cannabis products into most European markets and ensures that patients seeking medicinal cannabis treatments benefit from the highest quality and safety standards in manufacturing processes.

ZenPharm will commence shipments of dried cannabis produced by Zenabis's EU GMP compliant approved facility in Atholville, N.B., into the EU medicinal cannabis market upon receipt of its final licence requirement issued by the Malta Medicines Authority for the production of cannabis for medicinal and research purposes as afforded under Chapter 578 of the laws of Malta, which is expected to occur in the first quarter of 2021. ZenPharm has already signed its first supply agreement with a customer located in Germany with minimum volume commitments of 500 kilograms per year.

Shai Altman, chief executive officer of Zenabis, said: "The receipt of EU GMP certification by ZenPharm is a very significant accomplishment for the company. This, together with the pending cannabis licence, are the last elements that will allow ZenPharm and Zenabis to access the vast EU medicinal cannabis market, and we are looking forward to growing our footprint in this market."

About Zenabis Global Inc.

Zenabis is a significant Canadian licensed cultivator of medical and recreational cannabis. Zenabis employs staff from coast to coast, across facilities in Atholville, N.B., Langley, B.C., and Stellarton, N.S. Zenabis currently has three licensed cannabis cultivation facilities in Canada, together with its cannabis import, export and processing joint venture, ZenPharm, operating from Birzebbuga, Malta.

The Zenabis brand name is used in the cannabis medical market, and the Namaste, Blazery and Re-Up brand names are used in the cannabis adult-use recreational market.

We seek Safe Harbor.

© 2021 Canjex Publishing Ltd. All rights reserved.